Sentinus LLC’s Revolution Medicines RVMD Stock Holding History

Sentinus LLC’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$253K	Buy	+1,234	New	+$245K	0.02%	603

Other funds holding RVMD

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Sentinus LLC's RVMD Position: Q3 2026 in Review

Sentinus LLC opened a new position in Revolution Medicines (RVMD) in Q3 2026: 1,234 shares worth $253K. The stake represents 0.02% of the portfolio and ranks #603 among its holdings.

490 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

Sentinus LLC held 1,234 shares of Revolution Medicines worth $253K as of Q3 2026.
Revolution Medicines was a new Sentinus LLC position in Q3 2026.
Revolution Medicines made up 0.02% of Sentinus LLC's portfolio in Q3 2026, its #603 holding.
490 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Sentinus LLC's 13F filing for Q3 2026, filed 12 Nov 2026.